Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy

INTRODUCTION: Temozolomide and concomitant radiotherapy followed by temozolomide has been used as a standard therapy for the treatment of newly diagnosed glioblastoma multiform since 2005. A search for prognostic factors was conducted in patients with glioblastoma routinely treated by this strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Verlut, Clotilde, Mouillet, Guillaume, Magnin, Eloi, Buffet-Miny, Joëlle, Viennet, Gabriel, Cattin, Françoise, Billon-Grand, Nora Clelia, Bonnet, Emilie, Servagi-Vernat, Stéphanie, Godard, Joël, Billon-Grand, Romain, Petit, Antoine, Moulin, Thierry, Cals, Laurent, Pivot, Xavier, Curtit, Elsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990148/
https://www.ncbi.nlm.nih.gov/pubmed/27559302
http://dx.doi.org/10.4137/CMO.S38474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990148/
https://www.ncbi.nlm.nih.gov/pubmed/27559302
http://dx.doi.org/10.4137/CMO.S38474

Ejemplares similares